Development of human antibody against ADAM28, a key modulator of tumor microenvironmental factors in non-small cell lung carcinomas

被引：0
|
作者：
Mochizuki, S. [1 ,2 ]
Shimoda, M. [2 ]
Ueno, H. [1 ]
Okada, Y. [2 ,3 ]
机构：
[1] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama, Japan
[2] Keio Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] Juntendo Univ, Sch Med, Dept Pathophysiol Locomot & Neoplast Dis, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY | 2018年 / 99卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：A26 / A26
页数：1
相关论文
共 50 条
  • [1] ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis
    Ohtsuka, T
    Shiomi, T
    Shimoda, M
    Kodama, T
    Amour, A
    Murphy, G
    Ohuchi, E
    Kobayashi, K
    Okada, Y
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (02) : 263 - 273
  • [2] Evaluation of ADAM28 as a serological and histochemical marker for non-small cell lung cancers
    Kuroda, H.
    Shimoda, M.
    Kawamura, M.
    Nomori, H.
    Okada, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] ADAM28 is a serological and histochemical marker for non-small-cell lung cancers
    Kuroda, Hiroaki
    Mochizuki, Satsuki
    Shimoda, Masayuki
    Chijiiwa, Miyuki
    Kamiya, Kazunori
    Izumi, Yotaro
    Watanabe, Masazumi
    Horinouchi, Hirohisa
    Kawamura, Masahumi
    Kobayashi, Koichi
    Okada, Yasunori
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (08) : 1844 - 1856
  • [4] EXPRESSION AND CLINICAL VALUE OF ADAM28 IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER
    Lv, Y-L
    Yuan, D-M
    Luo, L.
    Wang, Q.
    Liu, H-B
    Miao, X-H
    Shi, Y.
    Song, Y.
    RESPIROLOGY, 2011, 16 : 160 - 160
  • [5] Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor
    Yan-ling Lv
    Dong-mei Yuan
    Qing-bo Wang
    Ping Zhan
    Liang Luo
    Tang-feng Lv
    Hong-bing Liu
    Yu-feng Li
    Jian Wen
    Yong Song
    Medical Oncology, 2012, 29 : 2633 - 2639
  • [6] Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor
    Lv, Yan-ling
    Yuan, Dong-mei
    Wang, Qing-bo
    Zhan, Ping
    Luo, Liang
    Lv, Tang-feng
    Liu, Hong-bing
    Li, Yu-feng
    Wen, Jian
    Song, Yong
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2633 - 2639
  • [7] DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
    Bao-Zhu Yuan
    Amy M Jefferson
    Kimberly T Baldwin
    Snorri S Thorgeirsson
    Nicholas C Popescu
    Steven H Reynolds
    Oncogene, 2004, 23 : 1405 - 1411
  • [8] DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas
    Yuan, BZ
    Jefferson, AM
    Baldwin, KT
    Thorgeirsson, SS
    Popescu, NC
    Reynolds, SH
    ONCOGENE, 2004, 23 (07) : 1405 - 1411
  • [9] Paradoxical concentration effect of a homodimerizing antibody against a human non-small cell lung cancer cell line
    Heinz Kohler
    Ann Jay Bryan
    Cancer Immunology, Immunotherapy, 2009, 58
  • [10] Paradoxical concentration effect of a homodimerizing antibody against a human non-small cell lung cancer cell line
    Kohler, Heinz
    Bryan, Ann Jay
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (05) : 749 - 758
12345